The story of Viagra, formerly marketed by copyright, presents a complex case study for stakeholders considering the drug sector. Despite its initial success and impact of billions in earnings , the patent https://bookmark-media.com/story21734663/sildenafil-and-a-pharma-sector-a-dangerous-investment